Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Rapt Therapeutics, Inc Company Investigated By The Portnoy Law Firm is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Attention AXT Investors: Company Investigated by the Portnoy Law Firm
LOS ANGELES, April 04, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises AXT, Inc. (“AXT” or the “Company”) (NASDAQ: AXTI) investors that the law firm has initiated an investigation on ... Read More
Attention Endeavor Group Holdings Investors: Company Investigated by the Portnoy Law Firm
LOS ANGELES, April 03, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Endeavor Group Holdings, Inc. (NYSE: EDR) ("Endeavor") investors that the law firm has initiated an investigation on ... Read More
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK, NY / ACCESSWIRE / April 5, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akero Therapeutics, Inc. ("Akero" or "the Company ... assist ... Read More
What Makes RAPT Therapeutics (RAPT) an Investment Choice?
RAPT Therapeutics, Inc. (NASDAQ:RAPT) is a clinical-stage immunology-based biopharmaceutical company. On March 21, 2024, RAPT Therapeutics, Inc. (NASDAQ:RAPT) stock closed at $8.51 per share. Read More
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zevra Therapeutics, Inc. (ZVRA)
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ ... Read More
FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin ... Read More
Checkpoint Therapeutics, Inc. (CKPT)
WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted ... Read More
Attention Doximity, Inc. Investors: Company Investigated by the Portnoy Law Firm
LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Doximity, Inc ... by the company through the practice of expedited revenue recognition. Following the release ... Read More
Attention Comtech Telecommunications. Investors: Company Investigated By The Portnoy Law Firm
The Portnoy Law Firm can provide ... Comtech announced in a press release the immediate dismissal of Ken Peterman from his roles as President and Chief Executive Officer. The company clarified ... Read More
Attention Equinix, Inc. Investors: Company Investigated by the Portnoy Law Firm
LOS ANGELES, March 20, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Equinix, Inc. (NASDAQ: EQIX) investors that the law firm has initiated an investigation ... the release of this ... Read More
Attention Comtech Telecommunications Investors: Company Investigated By The Portnoy Law Firm
The Portnoy Law Firm can provide ... Comtech announced in a press release the immediate dismissal of Ken Peterman from his roles as President and Chief Executive Officer. The company clarified ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus